TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: change in [18F]F-AraG uptake and tumor response
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Feasibility of SLN procedure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Activation state of oncogenic pathways
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Reporting of actionable genomic abnormalities
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Caries lesion
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in gait cadence (steps/minute)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in gait velocity (meter/minute)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in gait stride length (meter)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: HRQOL using Minnesota Living with Heart Failure Questionnaire
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Percentage of patients with significant nausea
Endpoint domain: Adverse events/effects
Primary endpoint: Percentage of suppression of endogenous glucose production
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Fertility Preparedness Scale for Women Receiving Fertility Treatment
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Residual Neuromuscular Block
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Chewing Ability Assessment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cancer Detection Rate of Clinically Significant Prostate Cancer
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Investigational device serious adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: Cancer Detection Rate of Clinically Insignificant Prostate Cancer
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: The Child Satisfaction Scale
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: P. falciparum gametocyte carriage
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Immediate adverse events after booster vaccination
Endpoint domain: Adverse events/effects
Primary endpoint: Solicited local and systemic adverse events within 7 days
Endpoint domain: Adverse events/effects
Primary endpoint: Unsolicited adverse events within 28 days
Endpoint domain: Adverse events/effects
Primary endpoint: Early postoperative uncorrected visual acuity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Generic self-reported quality of life
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Kidney disease quality of life
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Liver disease quality of life
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Diagnostic yield of clinically actionable arrhythmia
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Emotional control and regulation
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Short-term Post-operative Sensitivity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Safety of the tracer [18F]-Fluselenamyl
Endpoint domain: Adverse events/effects
Primary endpoint: Usability of Clinical Decision Support System (MedWise(TM))
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Acceptability of Clinical Decision Support System (MedWise(TM))
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Quality of Life (QOL) related to pharmacogenetics
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: AST and ALT liver enzymes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: proportion of patients with authentified idiopathic short stature
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Treatment Session Adherence Rate
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Average Client Satisfaction Questionnaire Score (CSQ-8)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Mean Score on MBCT-T/V Adherence & Competence Scales (MBCT-TACS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Buttocks circumference
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 10-meter walking time at comfortable pace
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 10-meter walking time at maximum pace
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Blood loss quantification
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: change from baseline in pain score at rest
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: change from baseline in pain score during coughing
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: incidence of chronic pain 3 months after surgery
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: American foot and ankle score
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Change in total Healthy Eating Index-2020 (HEI-2020) total score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Spleen Volume Reduction (SVR) at Week 24
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Minutes of moderate to vigorous intensity physical activity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Subjective effect duration
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Tissue volume of Distribution (Vt)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Patellofemoral Pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Skin allergy reaction
Endpoint domain: Adverse events/effects
Primary endpoint: Duration of mucosal adhesion
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Local anesthetic effect
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in opening urethral pressure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: ICF motor and sensitive domains dynamic
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: degree of kyphosis
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: NeuroPsychiatric Inventory (NPI) scale
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Maximum Tolerated Dose (MTD) of HS-20105
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Efficacy of HS-20105
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Accuracy during motion
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Self-Injurious Thoughts and Behaviors
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Post-Traumatic Stress Disorder Symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rate of Complete Remission with undetectable Measurable Residual Disease
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Treatment Emergent Adverse Events (AEs) During 7 Days After Experimental Treatment
Endpoint domain: Adverse events/effects
Primary endpoint: Treatment Emergent Adverse Events (AEs) During 28 Days After Experimental Treatment
Endpoint domain: Adverse events/effects
Primary endpoint: Serious Adverse Events (SAEs) Through 28 Days After Licensed IIV Treatment
Endpoint domain: Adverse events/effects
Primary endpoint: Improvement in Tinnitus
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Postictal blood flow
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Response of tumor models/organoids to chemotherapy
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Hypoventilation incidence
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Change in Modified Functional Reach Test (mFRT)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Postural Star-Sitting Test (PSST)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Neuromuscular junction transmission instability
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: IgG level assessment
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Turnaround time of genotype result
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Overall satisfaction of patient
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Prevalence of clinically actionable genotypes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Validation of the IdFAI scale
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Spirometry Measurements
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Medication adherence assessment
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Remission of the State of MN
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Area under the Curve (AUC) for Saliva
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Area under the Curve for Plasma
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cmax for Saliva
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cmax for Plasma
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Ankle Brachial Index (ABI)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Change in ulcer surface area
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of patients initiating the HPV vaccine
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Concentration of secretory immunoglobulin A (sIgA)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Percent of time in target glucose range
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Evaluation of intrabony component dimension
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Maternal participants app usability score
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Father/partner participants app usability score
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Maternal participants app engagement score
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Father/partner participants app engagement score
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: AUC from the 0 to infinity (AUC0-inf)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time of the maximum measured plasma concentration (Tmax)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: post-operative AKI incidence
Endpoint domain: Adverse events/effects
Primary endpoint: Tissue changes in diabetic patients
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Opioid Use at 24 Hours
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Safety signals for kidney function
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Safety signals for liver function
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Perceived Changes in Bloating and Stomach Distention
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: volatile organic compounds (VOC) profile
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Adverse events due to MSOT imaging
Endpoint domain: Adverse events/effects
Primary endpoint: Incidence of Post-Radiotherapy Nasolacrimal Duct Obstruction (NLDO)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Diagnostic Interview for Seizure Classification Outside of Video EEG Recording (DISCOVER)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of completed crises treated at home within the protocol
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Infant and young child-feeding practices
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Rate of intact perineum and perineal tears
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: DHCW Willingness to Participate in the Study
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: DHCW Test Completion
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Number of DHCW With Complete Surveys
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Hemodynamic Response
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Resting state connectivity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Incidence of Lumosity 6-game brain exercise completion
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Number of patients with no need to adapt PSI edges
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Number of patients with no need to augment/fill clefts between PSI and bone
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Proportion of full data sets and toxicology analysis
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean Oxygen Desaturation Index (ODI4%)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Log of Mean Apnea Hypopnea Index (AHI)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Occurrence of device-related serious adverse events (SADEs)
Endpoint domain: Adverse events/effects
Primary endpoint: change in Global Assessment of Functioning
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: change in working memory performance
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cognitive functioning
Primary endpoint: H-reflex latency and amplitude
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Wayfinding ability
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Heart Rate Variability - rMSSD
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Heart Rate Variability - LF absolute power
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Heart Rate Variability - VLF absolute power
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Heart Rate Variability - HF absolute power
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Heart Rate Variability - LF/HF power
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Frequency of Adverse Drug Reactions (ADR)
Endpoint domain: Adverse events/effects
Primary endpoint: bacterial contamination
Endpoint domain: Adverse events/effects
Primary endpoint: Freedom from device and/or procedure related Major Adverse Events (MAEs)
Endpoint domain: Adverse events/effects
Primary endpoint: Freedom from AF/AT/AFL following a blanking period
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: change in liver stiffness in terms of kPa
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Liver fat quantification
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Acceptability of treatment at 1-month follow-up
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Cerebral blood perfusion
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Change in substance use
Endpoint domain: Life impact
Endpoint subdomain: Personal circumstances
Primary endpoint: Incontinence Symptom Severity Index
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Exercise B-lines score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Low Back pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Children's Nail-Biting Knowledge
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Children's Nail-Biting Practice/Habits
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Children's Attitude and Self-efficacy Towards Nail-biting
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Subjective Norms and Enabling Factors of Nail-Biting Among Children
Endpoint domain: Life impact
Endpoint subdomain: Social functioning
Primary endpoint: Severity of COPD airflow restriction
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Cervical Pain Pressure Threshold (PPT)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Pulse values
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Positive rate of oncological contamination of peritoneal washings
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Vagal Efficiency (VE)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Change in FACT-Cog
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Change in Rey Auditory Verbal Learning Task
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Balance Task
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Activities Specific Balance Confidence Scale
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Area Under the Concentration-Time Curve (AUC0-Inf)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Response to CAR-T cell therapy
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: CRS toxicity to CAR-T cell therapy
Endpoint domain: Adverse events/effects
Primary endpoint: ICANS toxicity to CAR-T cell therapy
Endpoint domain: Adverse events/effects
Primary endpoint: Compliance to Prescribed Use
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Patient-reported Ease-of-use
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Number of participants with fluid responsiveness
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: maximum voluntary isometric contraction (MVIC)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Functional outcome (modified rankin scale)
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: AUClast of abiraterone
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Endoscopic Nasal Polyp Score (NPS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Average Daily Nasal Congestion Score (NCS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Oxygen Saturation Levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Change in ECG morphology
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Number of (Serious) Adverse Events
Endpoint domain: Adverse events/effects
Primary endpoint: Incidence of Functional esophageal disorders
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Local and systemic adverse events (AEs) related to the IMP after vaccination
Endpoint domain: Adverse events/effects
Primary endpoint: Any serious adverse events (SAE) occurring after the 1st vaccination
Endpoint domain: Adverse events/effects
Primary endpoint: Perianal fistula formation
Endpoint domain: Adverse events/effects
Primary endpoint: Recurrence of perianal abscess
Endpoint domain: Adverse events/effects
Primary endpoint: Accuracy of heart rate measurement
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Accuracy of heart rate variability index measurement
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Accuracy of breathing rate measurement
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Accuracy of instantaneous heart rate measurement
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Oxygenation indices
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes